NCT05194072CompletedPhase 1
A Study of SGN-B7H4V in Advanced Solid Tumors
Source: EU CTIS (euclinicaltrials.eu) · Last updated 23 Aug 2024
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 147 (actual)
- First submitted
- 14 Mar 2024
- Start date
- 31 Aug 2022
- Lead sponsor
- Seagen Inc.
- Diseases
- Triple-negative breast cancer, Endometrial cancer, Lung cancer, Liver and biliary tract cancer, Ovarian cancer
- NCT number
- NCT05194072
- EU CT number
- 2023-503389-22-00
- EudraCT number
- 2021-002107-35
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 147
- 7 sites in 4 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.
Sites (7)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Charite Research Organisation GmbH Coordinator of this site? Confirm its status | Berlin | Germany | Completed |
| Hospital Universitari Vall d'Hebron Coordinator of this site? Confirm its status | Barcelona | Spain | Completed |
| Hospital Universitario HM Sanchinarro Coordinator of this site? Confirm its status | Madrid | Spain | Completed |
| Institut Bergonie Coordinator of this site? Confirm its status | Bordeaux | France | Completed |
| Institut Gustave Roussy Coordinator of this site? Confirm its status | Villejuif | France | Completed |
| European Institute Of Oncology S.r.l. Coordinator of this site? Confirm its status | Milan | Italy | Completed |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS Coordinator of this site? Confirm its status | Rome | Italy | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.